Avillion US

Avillion is a clinical-stage drug development company that employs a unique co-development model to advance late-stage pharmaceutical assets. The company partners with large pharmaceutical firms to fund and execute Phase 3 clinical trials, assuming the financial and regulatory risks in exchange for milestone payments and royalties upon approval. Avillion's notable achievements include the development of Airsupra with AstraZeneca and the successful Phase 3 trial for Pfizer's Bosulif in chronic myeloid leukemia. Headquartered in London with a significant presence in the US, the company is supported by top-tier investors like Blackstone and Abingworth. Avillion focuses on optimizing the path to regulatory approval for high-potential therapies in respiratory, oncology, and other therapeutic areas.